![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/edging-toward-a-pivotal-readout-biogen-picks-a-new-discovery-partner-for-ophthalmic-gene-therapy/
https://www.fiercepharma.com/pharma/what-s-next-big-biopharma-m-a-target-uniqure-biogen-and-more-report
https://www.fiercebiotech.com/biotech/uniqure-weighs-sale-after-hemophilia-gene-therapy-turnaround-report
https://www.globenewswire.com/news-release/2019/04/16/1804751/0/en/Nightstar-Therapeutics-plc-Announcement-of-Expiry-of-HSR-Waiting-Period-and-Satisfaction-of-Antitrust-Condition.html
https://www.biopharmadive.com/news/pharmacquired-biogen-could-use-a-big-deal-too-bad-it-doesnt-do-those/551058/